Hugh Johnson Advisors’s AbbVie ABBV Stock Holding History

Hugh Johnson Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$200K	Hold	2,754	–	–	0.06%	92
2019 Q1	$222K	Buy	+2,754	New	+$225K	0.07%	91
2015 Q1	–	Sell	-51,825	Closed	-$3.39M	–	93
2014 Q4	$3.39M	Sell	51,825 -1,440	-3%	-$90.8K	1.18%	38
2014 Q3	$3.08M	Buy	53,265 +2,280	+4%	+$127K	1.1%	43
2014 Q2	$2.88M	Sell	50,985 -225	-0.4%	-$11.8K	1.05%	42
2014 Q1	$2.63M	Sell	51,210 -838	-2%	-$42.4K	0.99%	44
2013 Q4	$2.75M	Sell	52,048 -518	-1%	-$25.5K	1.08%	41
2013 Q3	$2.35M	Buy	52,566 +2,142	+4%	+$95K	1%	43
2013 Q2	$2.08M	Buy	+50,424	New	+$2.21M	0.95%	47

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Hugh Johnson Advisors's ABBV Position: Q2 2019 in Review

Hugh Johnson Advisors held its AbbVie (ABBV) position steady in Q2 2019 at 2,754 shares worth $200K. The position accounts for 0.06% of the portfolio, ranked #92.

Hugh Johnson Advisors first reported a position in ABBV in Q2 2013 and has held it in 9 quarters since. The position peaked at $3.39M in Q4 2014. 2,021 funds tracked by Wall St. Rank hold ABBV as of Q2 2019.

Hugh Johnson Advisors held 2,754 shares of AbbVie worth $200K as of Q2 2019.
Hugh Johnson Advisors left its AbbVie share count unchanged in Q2 2019.
AbbVie made up 0.06% of Hugh Johnson Advisors's portfolio in Q2 2019, its #92 holding.
Hugh Johnson Advisors first reported a position in AbbVie in Q2 2013 and has held it in 9 quarters since.
Hugh Johnson Advisors's AbbVie position peaked at $3.39M in Q4 2014.
2,021 funds tracked by Wall St. Rank held AbbVie as of Q2 2019.

Based on Hugh Johnson Advisors's 13F filing for Q2 2019, filed 6 Aug 2019.